Author:
Safa Malek,Foon Kenneth A.,Oldham Robert K.
Reference105 articles.
1. Andrew AM, Pim MV, Perkins AC, Baldwin RW. Comparative imaging and biodistribution studies with an anti-CEA monoclonal antibody and its F(ab)2 and Fab fragments in mice with colon carcinoma xenografts. Eur J Nucl Med 1986; 12: 168–75.
2. Avner B, Avner BP, Gaydos B et al. Characterization of a method using viable human target cells as the solid phase in a cell concentration fluorescence immunoassay (CCFIA) for screening of monoclonal antibodies and hybridoma supernatants. J Immunol Methods 1988; 113: 123–35.
3. Avner BP, Liao SK, Avner B et al. Therapeutic murine monoclonal antibodies developed for individual cancer patients. J Biol Response Modif 1989; 8: 25–36.
4. Avner B, Swindell L, Sharp E et al. Evaluation and clinical relevance of patient immune responses to intravenous therapy with murine monoclonal antibodies conjugated to adriamycin. Mol Biother 1991; 3: 14–21.
5. Bagshawe KD. Antibody directed enzymes activate pro-drugs at tumor site. Order SE, ed. Antibody Immunoconj Radiopharm 1990; 3: 60–5